Specialties
Hematology
Hematopoietic stem cell transplantation
Clinical Interests
Hematopoietic stem cell transplantation, cordblood transplantation and other novel cell therapies for patients with hematologic malignancis, especially refractory leukemia
Education
1991-1996 BS, Guangzhou Medical University, China, Medicine
2000-2003 MS, Sun Yat-sen University, China, Internal Medicine2008-2014 Ph.D, Jinan University, China, Internal Medicine1996-1999 Internal Medicine Resident, Guangdong Provincial People’s Hospital, China
2000-2002 Hematological Clinical Fellow, Department of Hematology, Guangdong Provincial People’s Hospital, China
2003-2007 Attending Physician, Department of Hematology, Department of Hematology,Guangdong Provincial People’s Hospital, China
2008-2018 Associate Professor & Associate Consultant Hematologist, Department of Hematology,Guangdong Provincial People’s Hospital, China
2018-2019 Visting Associate professor, Division of Hematologic malignancies and Cellular Therapy in the Department of Medicine, Duke University ,USA
2019-present Professor&Consultant Hematologist,,Department of Hematology, Guangdong Provincial People’s Hospital,Guangdong ,China
Awards and Honors
Science and technology progress prize in Guangdong province(2003)
Science and technology progress prize in Guangzhou city (2004)
Professional membership
2000-Member, Section of Hematology, Chinese Society for Medicine
2015- Committee Member, Cell Therapy of Guangdong Branch Association, Section of Hematology, Chinese Society for Medicine
2015- CommitteeMember, Section of Hematology, Guangdong Society for Immunology
2016- Standing Committee Member, Guangdong Branch Association, Section of Hematology, Chinese Medical Doctor Association
Pubications
-
Jialin Wu , Zehong Chen , Wenwei Liu , Yongxin Zhang , Wei Feng , Yujie Yuan 1 , Jinning Ye 1 , Liang Wang 1 , Shirong Cai 1 , Yulong He , Suijing Wu* , Wu Song .MicroRNA-188-5p targeting Forkhead Box L1 promotes colorectal cancer progression via activating Wnt/β-catenin signaling.2020,11doi: 10.3727/096504020X16061317886881(in English)
-
Chen Z, Wu J, Huang W, Peng J, Ye J, Yang L, Yuan Y, Chen C, Zhang C, Cai S, He Y, Wu S,* Song W.Long Non-Coding RNA RP11-789C1.1 Suppresses Epithelial to Mesenchymal Transition in Gastric Cancer Through the RP11-789C1.1/MiR-5003/E-Cadherin Axis.Cell Physiol Biochem. 2018;47(6):2432-2444 (in English)
-
Chen Z , Han S , Huang W , Wu J , Liu Y , Cai S , He Y , Wu S *, Song Wu. MicroRNA-215 suppresses cell proliferation, migration and invasion of colon cancer by repressing Yin-Yang 1.Biochem Biophys Res Commun 2016 9:482-488 (in English)
-
Wu SJ, Xu L,HuangX,Geng SX, XuY,ChenSH,YangLJ,WuXL,WengJY,DuX, LiYQ. Arsenic induced complete remission in a refractory T-ALL patient with a distinct T cell clonal evolution without molecular complete remission. Oncology Letters. 2016 11: 4123-4130 (in English)
-
Wu SJ,DuX,ShenWZ,LiYQ,LingW,WengJY,GuoR,ZhongLY,LinW.Effect of najanajaactra venom on K562/ADM and refractory acute myeloid leukemia cells.New Medicine.2013,44(1):68~72 (in Chinese)
-
Wu SJ, Du X, Weng JY, Lu ZS,Luo CW, Ling W, Lin W.Relapses after Allogeneic Hematopoietic Cell Transplantation.The Journal of Practical Medicine.2011,7:2614~2615 (in Chinese)
-
Wu SJ,Du X, Luo CW, Lin W.Serious Anemia following Allogeneic Stem Cell Transplantation.Chinese Journal of Internal Medicine. 2009,5:410~411 (in Chinese)Wu SJ, Du X, Weng JY, Luo CW, LuZS,Guo R, Ling W, Deng CX, Lin W, HuangZL. Abnormalities in coagulation in patient following allogeneic stem cell transplantation.Journal of ClinicalHematology.2009,22(4):348~351(in Chinese)
-
Wu SJ,Du X, Weng JY,Lu ZS, GuoR,LuoCW,WangCC,LingW,DengCX,LinW,Huang ZL. Hemolytic Anemia following Allogeneic Stem Cell Transplantation.International Journal of Blood Transfusion and Hematology.2009,32(2):114~116 (in Chinese)
-
Wu SJ,Du X, Lin W,HuangZL,Zhou XL, Weng JY,Zhong LY,Lu ZS. Cyclophosphamide, Ara-C and Topotecan (CAT) for Patients with Refractory or Relapsed Leukemia.Journal of Clinical Hematology. 2008,11:604~605 (in Chinese)
-
Wu SJ,Du X, Weng JY,Guo R, Lu ZS, Luo CW,Ling W, Deng CX,LinW,Huang ZL. Central Nervous System Complication following Allogeneic Stem Cell Transplantation.Chinese Journal of Hematology. 2008,29(8):572~573 (in Chinese)
-
Wu SJ,DuX,ShenWZ,LiYQ,LinW,HuangZL,WengJY,HuangZX,ZhouMH,SuJH,Lu ZS.Analysis on 104 cases of chronic myelomonocytic leukemia(CMML).Journal of Third Military Medical University. 2008,14(7):1391~1392 (in Chinese)
-
Wu SJ,Du X, Weng JY, ZhangJJ,,ZhouMH,HuangZX,GengSX,LinW,HuangZL. Effect of Naja NajaActraVenom on K562 and refractory leukemia cells.Journal of Modern Oncology. 2008,16(3):428~430 (in Chinese)
-
Wu SJ,DuX,Lin W, Weng JY, ZhangJJ,ZhouMH,HuangZX,HuangZL,LuZS,Chen YX. Efficacy and safety of gemtuzumabozogamicin(mylotarg)-based regimens in patients with CD33-positive refractoryleukemia.Journal of Modern Oncology. 2007,16(11):1650~1653 (in Chinese)
-
Wu SJ,Du X.Modified Topotecan Combination with Cyclophosphamide and Ara-C (CAT) for Patients with Refractory/Relapsed Leukemia Blood(ASH Annual Meeting Abstracts NOV 2007,110:4357) (in English)
-
Wu SJ,Du X.Efficacyand Safety of Gemtuzumab -Based Regimens in Patients with CD33-positive Refractory Leukemia, Blood(ASH Annual Meeting Abstracts NOV 2007,110:4358) (in English)
-
Wu SJ,DuX,Lin W, Zou XL,Weng JY, LuZS,HuangZL.,SurvivalAnalysis on 15Cases of Primary Macroglatulinemia.Journal of Clinical Hematology.2006,19(1):37~38 (in Chinese)
-
Wu SJ,DuX,ChenYX,Jiang WL, Lin W, Huang ZL. Effect ofCyclins in Refractory Acute Leukemia.Chinese Journal of Hematolog. 2005,26(7):433~434 (in Chinese)
-
Wu SJ,DuX,ChenYX,Jiang WL, ZhongLY,Lin W, Huang ZL. Relationship between Cyclins and Prognosis of Acute Leukemia. ,Chinese Journal of Cancer. 2003,22(8):852~854 (in Chinese)
-
Wu SJ,Du X, Weng JY,Lu ZS.SurvivalAnalysis on 104 Cases of Adult Acute Leukemia.Clinical Focus. 2003,18(12):666~669 (in Chinese)